AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+3.42%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$9.74B
AUM Growth
+$4.74B
(+95%)
Cap. Flow
+$4.51B
Cap. Flow
% of AUM
46.35%
Top 10 Holdings %
Top 10 Hldgs %
64.11%
Holding
550
New
164
Increased
124
Reduced
128
Closed
110
Top Buys
| 1 |
Microsoft
MSFT
|
$1.04B |
| 2 |
Apple
AAPL
|
$738M |
| 3 |
TSMC
TSM
|
$611M |
| 4 |
Global X Cybersecurity ETF
BUG
|
$521M |
| 5 |
Amazon
AMZN
|
$510M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$522M |
| 2 |
Synchrony
SYF
|
$162M |
| 3 |
Simon Property Group
SPG
|
$28.7M |
| 4 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
$21.2M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
$18.1M |
Sector Composition
| 1 | Technology | 42.39% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Communication Services | 12.44% |
| 4 | Consumer Staples | 6.28% |
| 5 | Financials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Bio-Techne
TECH
$8.46B
| $42K | ﹤0.01% |
440
-32
| -7% | -$3.06K |
|
302
The Joint Corp
JYNT
$163M
| $41K | ﹤0.01% |
856
-488
| -36% | -$23.4K |
|
303
Myriad Genetics
MYGN
$615M
| $41K | ﹤0.01% |
+1,341
| New | +$41K |
|
304
Envista
NVST
$3.54B
| $41K | ﹤0.01% |
+1,007
| New | +$41K |
|
305
OptimizeRx
OPRX
$349M
| $41K | ﹤0.01% |
+831
| New | +$41K |
|
|
CNH
306
CNH Industrial
CNH
$14.3B
| $41K | ﹤0.01% |
+3,022
| New | +$41K |
|
|
CDMO
307
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $41K | ﹤0.01% |
+2,236
| New | +$41K |
|
308
AtriCure
ATRC
$1.76B
| $40K | ﹤0.01% |
+608
| New | +$40K |
|
309
Integra LifeSciences
IART
$1.25B
| $40K | ﹤0.01% |
+578
| New | +$40K |
|
|
NUAN
310
DELISTED
Nuance Communications, Inc.
NUAN
| $40K | ﹤0.01% |
906
-1,232
| -58% | -$54.4K |
|
311
Axogen
AXGN
$735M
| $39K | ﹤0.01% |
1,913
-180
| -9% | -$3.67K |
|
312
Halozyme
HALO
$8.76B
| $39K | ﹤0.01% |
943
+44
| +5% | +$1.82K |
|
313
Jazz Pharmaceuticals
JAZZ
$7.86B
| $39K | ﹤0.01% |
238
-7
| -3% | -$1.15K |
|
|
NTUS
314
DELISTED
Natus Medical Inc
NTUS
| $39K | ﹤0.01% |
+1,535
| New | +$39K |
|
315
Accuray
ARAY
$170M
| $38K | ﹤0.01% |
+7,716
| New | +$38K |
|
316
Cisco
CSCO
$264B
| $38K | ﹤0.01% |
740
-138
| -16% | -$7.09K |
|
317
Castle Biosciences
CSTL
$683M
| $38K | ﹤0.01% |
558
-113
| -17% | -$7.7K |
|
318
DTE Energy
DTE
$28.4B
| $38K | ﹤0.01% |
+340
| New | +$38K |
|
319
Glaukos
GKOS
$5.39B
| $38K | ﹤0.01% |
+455
| New | +$38K |
|
320
Natera
NTRA
$23.1B
| $38K | ﹤0.01% |
373
-30
| -7% | -$3.06K |
|
|
RDUS
321
DELISTED
Radius Health, Inc.
RDUS
| $38K | ﹤0.01% |
+1,841
| New | +$38K |
|
|
HSKA
322
DELISTED
Heska Corp
HSKA
| $38K | ﹤0.01% |
+228
| New | +$38K |
|
323
Goldman Sachs
GS
$223B
| $37K | ﹤0.01% |
+114
| New | +$37K |
|
324
Orthofix Medical
OFIX
$575M
| $37K | ﹤0.01% |
+845
| New | +$37K |
|
325
Ultragenyx Pharmaceutical
RARE
$3.07B
| $37K | ﹤0.01% |
321
+41
| +15% | +$4.73K |
|